Health
RPT-Lonza confident of 2020 target for Moderna COVID-19 vaccine supply – Reuters
Lonza is confident that U.S. and Swiss plants it is building to help make Moderna’s COVID-19 vaccine candidate will be ready for commercial production this year…
(Repeating to add TV in slug)
* Lonza confident on 2020 target for Moderna vaccine
* Swiss locals watching, hoping for project success
* Swiss company focusing on drugs, selling chemicals unit
VISP, Switzerland, Sept 29 (Reuters) – Lonza is confident that U.S. and Swiss plants it is building to help make Modernas COVID-19 vaccine candidate will be ready for commercial production this year, executives at the Swiss company said on Tuesday.
New production lines at Lonzas site in Portsmouth, Ne…
-
Business21 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
General21 hours agoTop chess player Magnus Carlsen forced into draw in historic game against over 134,000 people
-
General21 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
Noosa News7 hours agoCommissioner thanks police officer who threw a speed radar at a car